Page 601 - Read Online

Ralph et al. J Cancer Metastasis Treat 2018;4:49 I http://dx.doi.org/10.20517/2394-4722.2018.42 Page 21 of 26

biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med 2012;53:1584-94.
10. MacGarvey NC, Suliman HB, Bartz RR, Fu P, Withers CM, Welty-Wolf KE, Piantadosi CA. Activation of mitochondrial biogenesis by
heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit
Care Med 2012;185:851-61.
11. Dominy JE, Puigserver P. Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb Perspect Biol
2013;5:pii: a015008.
12. Cherry AD, Suliman HB, Bartz RR, Piantadosi CA. Peroxisome proliferator-activated receptor γ co-activator 1-α as a critical co-activator of
the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis. J Biol Chem 2014;289:41-52.
13. Scarpulla RC. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann N Y Acad
Sci 2008;1147:321-34.
14. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R. The causes of cancer revisited: “mitochondrial malignancy”
and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol Aspects Med 2010;31:145-70.
15. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and
metabolism. Endocr Rev 2006;27:728-35.
16. Aquilano K, Baldelli S, Pagliei B, Cannata SM, Rotilio G, Ciriolo MR. p53 orchestrates the PGC-1α-mediated antioxidant response upon
mild redox and metabolic imbalance. Antioxid Redox Signal 2013;18:386-99.
17. Yin W, Signore AP, Iwai M, Cao G, Gao Y, Chen J. Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain
injury. Stroke 2008;39:3057-63.
18. Gravel SP. Deciphering the dichotomous effects of PGC-1α on tumorigenesis and metastasis. Front Oncol 2018;8:75.
19. LeBleu VS, O’Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A, Domingos Chinen
LT, Rocha RM, Asara JM, Kalluri R. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote
metastasis. Nat Cell Biol 2014;16:992-1003, 1-15.
20. LaGory EL, Wu C, Taniguchi CM, Ding CC, Chi JT, von Eyben R, Scott DA, Richardson AD, Giaccia AJ. Suppression of PGC-1α is
critical for reprogramming oxidative metabolism in renal cell carcinoma. Cell Rep 2015;12:116-27.
21. Taguchi A, Delgado O, Celiktaş M, Katayama H, Wang H, Gazdar AF, Hanash SM. Proteomic signatures associated with p53 mutational
status in lung adenocarcinoma. Proteomics 2014;14:2750-9.
22. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM, Puigserver P. PGC1α
expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer
Cell 2013;23:287-301.
23. Choi HI, Kim HJ, Park JS, Kim IJ, Bae EH, Ma SK, Kim SW. PGC-1α attenuates hydrogen peroxide-induced apoptotic cell death by
upregulating Nrf-2 via GSK3β inactivation mediated by activated p38 in HK-2 Cells. Sci Rep 2017;7:4319.
24. Sen N, Satija YK, Das S. PGC-1α, a key modulator of p53, promotes cell survival upon metabolic stress. Mol Cell 2011;44:621-34.
25. Popowich DA, Vavra AK, Walsh CP, Bhikhapurwala HA, Rossi NB, Jiang Q, Aalami OO, Kibbe MR. Regulation of reactive oxygen
species by p53: implications for nitric oxide-mediated apoptosis. Am J Physiol Heart Circ Physiol 2010;298:H2192-200.
26. Lisek K, Campaner E, Ciani Y, Walerych D, Del Sal G. Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of
cancer cells. Oncotarget 2018;9:20508-23.
27. Clemons NJ, Liu DS, Duong CP, Phillips WA. Inhibiting system xC- and glutathione biosynthesis - a potential Achilles’ heel in mutant-p53
cancers. Mol Cell Oncol 2017;4:e1344757.
28. Liu DS, Duong CP, Haupt S, Montgomery KG, House CM, Azar WJ, Pearson HB, Fisher OM, Read M, Guerra GR, Haupt Y, Cullinane C,
Wiman KG, Abrahmsen L, Phillips WA, Clemons NJ. Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53
accumulation. Nat Commun 2017;8:14844.
29. Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, Gu W. NRF2 is a major target of ARF in p53-independent tumor suppression. Mol Cell
2017;68:224-32.
30. Todoric J, Antonucci L, Di Caro G, Li N, Wu X, Lytle NK, Dhar D, Banerjee S, Fagman JB, Browne CD, Umemura A, Valasek MA,
Kessler H, Tarin D, Goggins M, Reya T, Diaz-Meco M, Moscat J, Karin M. Stress-activated NRF2-MDM2 cascade controls neoplastic
progression in pancreas. Cancer Cell 2017;32:824-39.
31. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y,
Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. The selective autophagy substrate p62 activates the
stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010;12:213-23.
32. Kapuy O, Papp D, Vellai T, Bánhegyi G, Korcsmáros T. Systems-level feedbacks of NRF2 controlling autophagy upon oxidative stress
response. Antioxidants (Basel) 2018;7:pii: E39.
33. Li P, Zhang D, Shen L, Dong K, Wu M, Ou Z, Shi D. Redox homeostasis protects mitochondria through accelerating ROS conversion to
enhance hypoxia resistance in cancer cells. Sci Rep 2016;6:22831.
34. Kim B, Song YS. Mitochondrial dynamics altered by oxidative stress in cancer. Free Radic Res 2016;50:1065-70.
35. Lo SC, Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp Cell Res 2008;314:1789-803.
36. Tian H, Zhang B, Di J, Jiang G, Chen F, Li H, Li L, Pei D, Zheng J. Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL. Cancer
Lett 2012;325:26-34.
37. Giudice A, Arra C, Turco MC. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by
chemopreventive agents. Methods Mol Biol 2010;647:37-74.
38. Dinkova-Kostova AT, Fahey JW, Kostov RV, Kensler TW. KEAP1 and done? Targeting the NRF2 pathway with sulforaphane. Trends Food
Sci Technol 2017;69:257-69.
39. Sihvola V, Levonen AL. Keap1 as the redox sensor of the antioxidant response. Arch Biochem Biophys 2017;617:94-100.
40. Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 2013;27:2179-91.